DataPort




Caleco Pharma Corp.

Ticker Symbol
OTCBB: CAEH



















New Interview with Jim Metropoulos, MD
Advisor for Product Development and Marketing


Caleco Pharma Web Site Link




Caleco Pharma brings science and credibility to a newly evolving multi-billion dollar business sector. Implementing a highly profitable business model – proven in the “old school” pharmaceutical world – to the rapidly growing bionutritional world, the company is being led by an aggressive and experienced management team, working to commercialize the company's existing pipeline and prepare the recently in-licensed compounds for further research development and market introduction. The Caleco Pharma pipeline targets large health care market segments in North America, South America and Europe with over 200MM potential customers.

The company identifies and develops products derived from natural sources including plant extracts, functional oils and probiotics and employs a dual-pathway model for product development and commercialization that allows it to diversify product distribution across various geographic and demographic markets and maximize speed-to-market dynamics for its OTC food supplement product pipeline while developing proprietary derivative formulations of its natural plant-based extracts as potential pharmaceuticals.